                            NIH Public Access
                            Author Manuscript
                            Mol Microbiol. Author manuscript; available PMC 2009 June 8.
                           Published final edited form 
NIH-PA Author Manuscript




                            Mol Microbiol. 2009 March ; 71(6): 1386â€“1401. doi:10.1111/j.1365-2958.2009.06610.x.



                           Methylene tetrahydrofolate dehydrogenase/cyclohydrolase                            synthesis 10-CHO-THF essential Leishmania major

                           Silvane M. F. Murta*,Â§, Tim J. Vickers*, David  ScottÂ§Â§, Stephen M. Beverley1
                           Department Molecular Microbiology, Box 8230, Washington University School Medicine, 660
                           S. Euclid Avenue, St. Louis, MO 63110, USA

                           Summary
                                10-formyl tetrahydrofolate key metabolite C1 carbon metabolism, arising action
                                formate-tetrahydrofolate ligase (FTL) 5,10-methenyltetrahydrofolate cyclohydrolase/5,10-
                                methylene tetrahydrofolate dehydrogenase (DHCH). Leishmania major possesses single DHCH1
                                FTL genes encoding exclusively cytosolic proteins, unlike organisms isoforms occur
NIH-PA Author Manuscript




                                mitochondrion  Recombinant DHCH1 showed typical NADP+-dependent methylene
                                tetrahydrofolate DH 5,10-methenyltetrahydrofolate CH activities, DH activity                                 potently inhibited substrate analog 5,10 THF (Ki 105 nM), Leishmania growth
                                (EC50 1.1 Î¼M). Previous studies showed null ftlâˆ’ mutants normal, raising possibility                                 loss purine synthetic pathway rendered 10-CHO-THF dispensable evolution.                                 unable generate dhch1âˆ’ null mutants gene replacement, despite using wide spectrum                                 nutritional supplements expected bypass DHCH function. applied improved method                                 testing essential genes Leishmania, based segregational loss episomal complementing
                                genes transfection; analysis ~1400 events successful loss DHCH1                                 established requirement. Lastly, employed â€˜genetic metabolite complementationâ€™ using
                                ectopically expressed FTL alternative source 10-CHO-THF; dhch1âˆ’ null parasites                                 readily obtained. data establish requirement 10-CHO tetrahydrofolate metabolism L.
                                major, provide genetic pharmacological validation DHCH target chemotherapy,
                                potentially protozoan parasites.


                           Keywords
                                trypanosomatid protozoa; C1-THF metabolism; 1 carbon transfer; chemotherapy; formyl methionyl-
NIH-PA Author Manuscript




                                tRNA


                           Introduction
                                            Leishmania important pathogens infecting millions people worldwide. symptoms
                                            infections range skin lesions disfiguring necrosis face, lethal
                                            pathology liver spleen, depending Leishmania species involved.                                             lasting immunity possible, vaccine presently available, drugs used                                             chemotherapy suffer various deficiencies, toxicity, high cost emerging


                           1For correspondence. E-mail: E-mail: beverley@borcim.wustl.edu. Tel. (+1) 314-747-2632; FAX. (+1) 314-747-2634;.
                            authors contributed equally work
                           Â§Present address: Centro Pesquisas Rene Rachou, FIOCRUZ, Belo Horizonte, Minas Gerais, 30190-002, Brazil
                           Â§Â§Present address: Burnham Institute Medical Research, 10901 North Torrey Pines Road, La Jolla, CA 92037
                           Supplemental information â€œMethylene tetrahydrofolate dehydrogenase/cyclohydrolase synthesis 10-CHO-THF                            essential Leishmania majorâ€?, Silvane M. F. Murta, Tim J. Vickers, David  Scott, Stephen M. Beverley.
                            Murta et al.                                                                                               Page 2


                                          resistance (Kedzierski et al., 2006, Mishra et al., 2007). Consequently, development                                           alternative therapies urgent priority.
NIH-PA Author Manuscript




                                          Folate derivatives essential cellular cofactors synthesis thymidine, purines                                           amino acids glycine methionine, metabolism histidine serine (Nzila et al.,
                                          2005, Christensen & MacKenzie, 2006) mitochondrial protein synthesis                                           formylation initiator methionyl-tRNAMet (Kozak, 1983). metabolism reduced folate
                                          cofactors particular drug discovery, dihydrofolate reductase (DHFR)                                           efficiently targeted anti-tumor anti-microbial chemotherapy (Nzila et al., 2005,
                                          Schweitzer et al., 1990,  2004). current antifolates ineffective                                           Leishmania DHFR inhibition bypassed pteridine reductase 1 (PTR1),                                           relatively insensitive (Bello et al., 1994), combined inhibitor strategies overcome                                           (Hardy et al., 1997, Cavazzuti et al., 2008). work explore potential new arena                                           chemotherapy, enzymes responsible synthesis 10-formyl tetrahydrofolate (10-
                                          CHO-THF).

                                          known enzyme activities mediate production 10-CHO-THF (Fig. 1) (Christensen &
                                          Mackenzie, 2008,Christensen & MacKenzie, 2006,Appling, 1991). pathway formate                                           added directly THF ATP-dependent reaction formate-tetrahydrofolate ligase
                                          (FTL, EC 6.3.4.3) (Rabinowitz & Pricer, 1962). Alternatively, 10-CHO-THF arises                                           steps 5,10-methylene-tetrahydrofolate (5,10-CH2-THF), beginning oxidation NIH-PA Author Manuscript




                                          5,10-methenyl-tetrahydrofolate (5,10-CH=THF) NADP+ NAD+-dependent
                                          methylenetetrahydrofolate dehydrogenase (DH, EC 1.5.1.5 1.5.1.15, respectively) (Moore
                                          et al., 1974,Hatefi et al., 1957). 5,10-CH=THF hydrolyzed 10-CHO-THF                                           methenyltetrahydrofolate cyclohydrolase (CH, EC 3.5.4.9). enzymes occur physically
                                          various combinations, monofunctional enzymes human, bacterial plant
                                          FTLs, bifunctional enzymes dehydrogenase cyclohydrolase activities (referred                                           DHCH enzymes), trifunctional enzymes activities (referred C1-THF
                                          synthases) (Christensen & Mackenzie, 2008,Christensen & MacKenzie, 2006,Appling,
                                          1991,Nour & Rabinowitz, 1991,Tan et al., 1977). Adding complexity, multiple genes
                                          encode activities single organism, humans expressing trifunctional
                                          C1-synthase cytoplasm (MTHFD1), bifunctional DHCH (MTHFD2)                                           monofunctional FTL (MTHFD1L) targeted mitochondrion (Christensen et al., 2005b).
                                          eukaryotes express differing combinations cytosolic organellar DHCH                                           FTLs (Christensen & MacKenzie, 2006,Hanson & Roje, 2001).

                                          products enzymes known functions. 5,10-CH=THF best-
                                          known intermediate leading 10-CHO-THF (Hanson & Roje, 2001, Christensen &
                                          MacKenzie, 2006, Appling, 1991), occurs DNA photolyases, NIH-PA Author Manuscript




                                          functions mammalian histidine catabolism (Weber, 2005, Stanger, 2002). pathways
                                          described Leishmania properties organisms suggest                                           unlikely essential. 10-CHO-THF acts formyl donor purine biosynthesis,                                           bacteria eukaryotic organelles formylation initiator methionyl-tRNAMet                                           produce fMet-tRNAMet (Appling, 1991, Christensen & MacKenzie, 2006, RajBhandary,
                                          1994, Varshney et al., 1993, Kozak, 1983). Interestingly, protozoans including
                                          trypanosomes Leishmania lack novo purine pathway rely exclusively salvage
                                          (Carter et al., 2008), eliminating need 10-CHO-THF capacity. importance
                                          initiator Met-tRNAMet formylation subject controversy. thought
                                          originally essential bacteria, recent data suggest case (Newton
                                          et al., 1999, RajBhandary, 2000). Mitochondrial initiator Met-tRNAMet formylation                                           dispensable yeast Saccharomyces cerevisae required humans;                                           essential, consequences loss vary widely (Li et al., 2000, Spencer & Spremulli,
                                          2004, Vial et al., 2003). Studies protozoal parasite Trypanosoma brucei, member 

                                               Mol Microbiol. Author manuscript; available PMC 2009 June 8.
                            Murta et al.                                                                                              Page 3


                                          protozoal subfamily Trypanosomatidae Leishmania belongs, Met-tRNA
                                          imported mitochondrion formylated, used mitochondrial
                                          protein synthesis (Tan et al., 2002, Charriere et al., 2005). RNAi knockdown formyl-
NIH-PA Author Manuscript




                                          Met-tRNAMet transferase (FMT) shows little phenotype.  negative results RNAi
                                          knockdowns arise incomplete inhibition, particular problem                                           cofactor metabolism low levels THF-dependent metabolites fulfill normal
                                          metabolic needs. Importantly, simultaneous RNAi knockdown T. brucei FMT                                           mitochondrial initiation factor IF2 yield significant growth inhibition (Charriere et al., 2005),
                                          possibly signifying importance fMet-tRNAMet essential mitochondrial protein
                                          synthesis.

                                          Previously used database mining survey 10-CHO-THF synthetic pathway
                                          Leishmania trypanosomatids (Vickers et al., 2008, Opperdoes & Coombs,
                                          2007). L. major genome encodes active monofunctional FTL predicted
                                          bifunctional DHCH encoded DHCH1 gene. proteins localized exclusively
                                          cytoplasm consistent absence predicted N terminal mitochondrial targeting
                                          sequence, shown immunoblotting cellular fractions GFP fusions                                           DHCH1 (Vickers et al., 2008). Unexpectedly, ftlâˆ’ null mutants showed normal viability                                           virulence. noted  absence purine synthesis mitigates need 10-CHO-
                                          THF Leishmania, potentially reduce eliminate requirement
                                          globally.
NIH-PA Author Manuscript




                                          characterize role DHCH1 L. major metabolism enzymatic, genetic
                                          knockout, pharmacological tests. DHCH1 encodes functional protein
                                          NADP-dependent DH CH activities, kinetic properties similar seen                                           organisms. used traditional transfection-based new plasmid segregational
                                          approach establish DHCH1 essential. Notably, expression FTL enabled                                           recovery dhch1âˆ’ mutants, establishing â€˜genetic metabolite complementationâ€™                                           10-CHO-THF essential. Lastly showed Leishmania growth DHCH1 activity                                           inhibited specific DHCH inhibitor. total data provide genetic                                           pharmacological validation DHCH target anti-parasitic chemotherapy.

                              Results
                              Enzymatic activity recombinant L. major DHCH1
                                          Previously used database mining trypanosomatid genomes identify gene LmjF26.0320
                                          DHCH1 functional DHCH Leishmania major (Vickers et al., 2008).                                           hexahistidine-tagged DHCH1 expressed E. coli recombinant protein                                           purified metal-affinity chromatography (Supplementary Figure S1) (Vickers et al., 2008).
NIH-PA Author Manuscript




                                          Dehydrogenase activity measured following conversion 5,10-CH2-THF 5,10-
                                          CH=THF, cyclohydrolase activity monitored following consumption                                           5,10-CH=THF, yielding 10-CHO-THF  methods). Purified DHCH1 showed 5,10-
                                          CH2-THF dehydrogenase 5,10-CH=THF cyclohydrolase activities, specific activities
                                          22 Â± 2 6.3 Â± 0.8 Î¼mol minâˆ’1 mgâˆ’1, respectively. comparison activities                                           porcine cytosolic multifunctional C1-synthase L. major enzyme slightly higher
                                          dehydrogenase activity lower cyclohydrolase activity, porcine enzyme having
                                          activities 7.5 22 Î¼mol minâˆ’1 mgâˆ’1, respectively (Tan et al., 1977).

                                          kinetic properties dehydrogenase reaction determined summarized                                           Table 1. reaction followed typical Michaelis-Menten kinetics saturated                                           substrate. mammals, cytoplasmic DH activity trifunctional C1-synthase                                           dependent NADP+ (Tan et al., 1977), mitochondrial DH dependent NAD
                                          + (Mejia & MacKenzie, 1988). L. major DHCH1 dehydrogenase activity highly


                                               Mol Microbiol. Author manuscript; available PMC 2009 June 8.
                            Murta et al.                                                                                               Page 4


                                          dependent NADP+, activity detected NAD+ (limit detection 0.3 Î¼mol
                                          minâˆ’1 mgâˆ’1, 1  activity seen NADP+). DH activity human
                                          mitochondrial DHCH NAD+ requires phosphate magnesium ions (Christensen et
NIH-PA Author Manuscript




                                          al., 2005a), tested presence 5 mM (K+)PO4 5 mM MgCl2 L. major
                                          DHCH1 showed NAD+-dependent activity (data shown). data consistent
                                          conservation residues LmDHCH1 interact NADP+ cofactor                                           human cytosolic enzyme, notably Arg173 interacts coenzyme 2â€™ phosphate group
                                          human enzymeâ€™s active site (Allaire et al., 1998) (Fig. S2). comparison human
                                          enzymes, Leishmania DHCH1 dehydrogenase activity appears similar                                           NADP+-dependent cytoplasmic C1 synthase, lower Km coenzyme lower
                                          turnover human mitochondrial DHCH MTHFD2 (Pawelek & MacKenzie, 1998).

                              Attempts generate DHCH1 knockout â€˜classicâ€™ double replacements
                                          Leishmania predominantly diploid inactivation genes requires rounds
                                          gene replacement (Cruz et al., 1991). chromosomes aneuploidy                                           WT Leishmania strains, preliminary CGH data suggest Chromosome 26 bearing
                                          DHCH1 disomic L. major line studied (E. Kruvand S. Beverley,                                           preparation).  constructed targeting fragments, DHCH1 ORF replaced
                                          ones encoding puromycin (PAC) hygromycin B (HYG) resistance, flanked ~ 1 kb                                           5â€² 3â€² sequence (Fig. 2A). Electroporation fragment separately WT L. major
                                          followed plating selective media yielded transfectant colonies efficiently control
NIH-PA Author Manuscript




                                          frequencies  shown). Analysis 20 clonal transfectant lines showed                                           heterozygotes (DHCH1/Î”dhch1::PAC DHCH1/Î”dhch1::HYG, abbreviated                                           PAC/+ HYG/+) expected (Fig 2A, Supplementary Figure S3, data shown).                                           studies used PCR tests primer pairs containing located outside targeting
                                          fragment 5â€² 3â€²  partnered marker-specific primer (Fig. S3, 2B, 2C
                                          data shown).

                                          HYG/+ PAC/+ heterozygotes submitted second round electroporation
                                          remaining targeting fragment (PAC HYG respectively) plated semisolid
                                          media containing puromycin hygromycin B. PCR tests 12 doubly resistant clonal
                                          transfectant lines showed contained planned HYG PAC DHCH1
                                          replacements (Fig 2B, 2C). Nonetheless, clonal transfectants retained copy DHCH1,
                                          revealed PCR amplification intact DHCH1 ORF (Fig. 2D), grew normally (data
                                          shown). finding successful â€˜double replacementâ€™ accompanied retention                                           WT gene seen previously attempts target essential genes Leishmania,
                                          arising generation aneuploid tetraploid parasites additional chromosomes
                                          bearing target gene (Balana-Fouce et al., 2008, Cruz et al., 1993, Dumas et al., 1997, Ilgoutz
                                          et al., 1999a, Vergnes et al., 2005). Analysis DNA content doubly-targeted lines
NIH-PA Author Manuscript




                                          flow cytometry showed WT DNA contents (data shown), suggested                                           likely aneuploids, bearing â€˜WTâ€™ chromosome planned
                                          HYG PAC replacements (Fig. 2A).

                              Attempts generate DHCH1 knockout double replacement using different nutritional
                              supplements
                                          attempted bypass consequences DHCH1 ablation metabolic
                                          complementation. studies, 2nd round transfections repeated,                                           parasites grown plated media containing various supplements potentially able bypass
                                          DHCH1 requirement. included metabolites known participate arise                                           C1 folate metabolism, including glycine, serine, formate, tetrahydrofolate, thymidine                                           folinic acid. Second, parasites grown supplements plus C1 folates
                                          5,10-CH=THF 10-formylfolic acid (10-CHOFA), intermediate


                                               Mol Microbiol. Author manuscript; available PMC 2009 June 8.
                            Murta et al.                                                                                             Page 5


                                          metabolite formed DH activity DHCH1 second constituting potential
                                          precursor 10-formyl-THF. ideal supplement 10-CHO-THF,                                           metabolite unstable;  mildly alkaline pH Leishmania culture media
NIH-PA Author Manuscript




                                          (7.4), spontaneous isomerization 5,10-CH=THF 10-CHO THF occurs time
                                          (Rabinowitz, 1963, Brouwer et al., 2007). Lastly, expected role 10-CHO-THF                                           Leishmania arises role mitochondrial protein synthesis, attempted bypass
                                          potential requirement performing transfections presence pyruvate uridine,
                                          metabolites proposed bypass need mitochondrial DNA                                           presumably proteins encoded (Sen et al., 2007).

                                          total, 65 independent clonal lines analyzed, yielded presumptive
                                          aneuploidy phenotype PCR assay described (data shown), e. parasites
                                          bearing planned HYG PAC replacements retaining copy                                           DHCH1 ORF, recovery dhch1âˆ’ null mutants.

                              Deletion chromosomal DHCH1 presence ectopically expressed DHCH1
                                          important control successful targeting achieved presence                                           ectopic DHCH1 expression, render unlikely possibility molecular events
                                          anticipated tested strategy occurred.  DHCH1 expressed
                                          multicopy episomal pXNG4 vector, bears nourseothricin (SAT) resistance
                                          marker (D. Scott S. Beverley, preparation). DHCH assays WT protein extracts showed
NIH-PA Author Manuscript




                                          specific activity 1 nmolâˆ’1 minâˆ’1 mg, value significantly different assay
                                          background controls lacking NADP+, WT/pXNG4-DHCH1 transfectants showed
                                          specific activity 31 nmolâˆ’1 minâˆ’1 mg, 30-fold greater. pXNG4-DHCH1                                           introduced HYG/+ PAC/+ heterozygotes described previously, second
                                          chromosomal allele lines targeted transfection (Fig. 3A). visualize                                           chromosomal DHCH1 allele, PCR using forward primer located 5â€² outside                                           DHCH1 targeting fragment reverse primer located DHCH1 ORF used
                                          (Fig. 3B).

                                          contrast results parasites lacking ectopic DHCH1 expression,                                           chromosomal DHCH1 readily lost 12 independent clonal transfectants tested
                                          (Fig. 3B). PCR tests showed lines contained HYG PAC Î”dhch1âˆ’
                                          replacements, retaining DHCH1 ORF borne pXNG4-DHCH1 (data shown).
                                           presence ectopically expressed DHCH1, chromosomal DHCH1 alleles
                                          successfully eliminated, yielding parasites genetically dhch1âˆ’/+pXNG4-
                                          DHCH1. methodological controls support conclusion                                           conditions tested, DHCH1 essential.
NIH-PA Author Manuscript




                              Genetic metabolite complementation permits recovery DHCH1 replacement
                                          requirement DHCH1 somewhat surprising, Leishmania possess second
                                          cytoplasmic pathway 10-CHO-THF synthesis formyl tetrahydrofolate ligase
                                          (FTL), enzymatic activity verified (Vickers et al., 2008) (Fig. 1).                                           indicate DHCH1 unanticipated function, alternatively, activity                                           FTL pathway insufficient metabolic needs absence DHCH1.  evidence
                                          FTL pathway secondary importance comes fact ftlâˆ’ mutants                                           readily generated apparent effect growth vitro virulence animal
                                          infections (Vickers et al., 2008).

                                          asked provision 10-CHO-THF expression FTL using                                           multicopy episomal vector pXNG4-FTL bypass requirement DHCH1 (Fig. 4A).
                                          pXNG4-FTL introduced heterozygous +/PAC +/HYG lines, FTL 


                                               Mol Microbiol. Author manuscript; available PMC 2009 June 8.
                            Murta et al.                                                                                               Page 6


                                          expression confirmed western blot analysis (Supplementary Figure S4). parasites
                                          submitted second round targeting  Analysis 12 independent
                                          transfectant lines showed lacked DHCH1 ORF entirely, western blot
NIH-PA Author Manuscript




                                          analysis polyclonal anti-DHCH1 antiserum confirmed complete loss DHCH1
                                          protein (Fig. 4B, C). ability elevated FTL expression enable parasites readily
                                          dispense DHCH1 strong evidence genetic metabolite complementation, presumably
                                          product FTL activity, 10-CHO-THF, turn argues strongly essential
                                          role DHCH1 provision metabolite.

                              Forcing loss pXNG4-DHCH1 negative selection
                                          final test probing essentiality DHCH1 WT Leishmania, applied method
                                          building â€˜plasmid shufflingâ€™ approaches common yeast genetics. Plasmid segregation
                                          based approaches advantage allowing separation tests gene function                                           transfection, relatively inefficient (D. Scott S.M. Beverley, preparation).                                           studies utilized features episomal pXNG4 vector, presence                                           negative selective marker  modified HSV thymidine kinase gene) positive GFP
                                          fluorescence marker (Fig. 5A). starting point dhch1âˆ’/pXNG4-DHCH1 parasite
                                          described earlier, chromosomal DHCH1 ablated parasite growth maintained
                                          episomal pXNG4-DHCH1 (Fig. 3, 5A).

                                          dhch1âˆ’/pXNG4-DHCH1 parasites grown briefly (24 h, ~3 doublings) absence
NIH-PA Author Manuscript




                                          nourseothricin (selective SAT marker episomal pXNG4) presence                                           ganciclovir, action HSV TK selects parasites bearing pXNG4.
                                          period little effect parasite growth seen.  parasites subjected                                           flow cytometry, assess plasmid copy number following expression GFP marker.
                                          populations cells evident following treatment:  â€˜brightâ€™ cells showing
                                          strong fluorescence (>200 FU; M2 gate Fig. 5B) presumably high copy numbers                                           pXNG4-DHCH1; â€˜dimâ€™ cells, showing background fluorescence (2â€“20 FU; M1 gate                                           Fig. 5B), presumably lacking pXNG4-DHCH1, bearing just copies. Controls
                                          showed absence ganciclovir dhch1âˆ’/+pXNG4-DHCH1 parasites retained high
                                          GFP fluorescence, WT cells showed background fluorescence (Fig. 5C, 5D).                                           previous results indicated DHCH1 essential, expected â€˜brightâ€™ cells
                                          retaining pXNG4-DHCH1 viable, â€˜dimâ€™ cells suffer growth
                                          disadvantage perish.

                                          used flow cytometry select single cells individual wells 96 microtiter plate,
                                          focusing â€˜dimâ€™ (M1) â€˜brightâ€™ (M2) parasites M1 population shown Fig.
                                          5B. inoculated parasites plates containing M199 media containing puromycin                                           hygromycin B  guarantee retention dhch1âˆ’ cells) lacking ganciclovir nourseothricin
NIH-PA Author Manuscript




                                          (pXNG4 markers). experiments performed media supplemented additionally
                                          various metabolites described earlier.

                                          studies, 478/672 wells inoculated single â€˜brightâ€™ parasite grew (71
                                           ), value similar seen controls probing effects sorting, recovery growth
                                          single cells cells (50 â€“ 80 ). contrast, wells receiving single â€˜dimâ€™ parasite,
                                          growth seen 48/2016 (2.4  ) (Fig. 5B). Importantly, 48 â€˜dimâ€™ parasite lines
                                          retained pXNG4-DHCH1 plasmid, judged ability grow presence                                           nourseothricin (SATR) DHCH1 PCR tests. presume cells arose                                           imperfect sorting, cells originally expressing low levels GFP presence
                                          copies pXNG4-DHCH1. correcting intrinsic plating
                                          efficiency, estimate total approximately 1430 cells (71  2016) scored
                                          ability grow absence DHCH1. plasmid shuffling enabled extend



                                               Mol Microbiol. Author manuscript; available PMC 2009 June 8.
                            Murta et al.                                                                                              Page 7


                                           stringency selection total 65 events scored â€˜classicâ€™ transfection
                                           based approach, value 20-fold higher.
NIH-PA Author Manuscript




                              Interaction L. major DHCH1 novel antifolates
                                           corroborate conclusion DHCH activity essential Leishmania growth,                                            turned pharmacological tests. substrate analogue 5,10 THF ((2S)-2-[[4-[(6aR)-3-
                                           amino-1,9-dioxo-5,6,6a,7-tetrahydro-4H- imidazol[3,4-f]pteridin-8-yl]benzoyl]amino]
                                           pentanedioic acid) previously shown potent inhibitor DHCH activity                                            human cytosolic C1-synthase (Tonkinson et al., 1998, Temple et al., 1982). predicted                                            compound potent inhibitor Leishmania DHCH1, based overall
                                           sequence conservation, including residues shown intact inhibitor structural
                                           studies human C1-synthase DHCH domain (Schmidt et al., 2000) (Fig. S2). 
                                           5,10 THF potent inhibitor DH activity recombinant Leishmania DHCH1,
                                           data fitting simple competitive model respect 5,10-CH2-THF, giving                                            Ki 105 Â± 2 nM (Fig. 6). 10-fold higher Ki 18 Â± 5 nM seen                                            DH activity human cytosolic C1-synthase (Schmidt et al., 2000). 5,10 THF
                                           shown previously weak inhibitor human DHFR (Ki > 100 Î¼M) (Temple et
                                           al., 1982), 100 Î¼M 5,10 THF did inhibit activity Leishmania DHFR-TS (data
                                           shown) FTL (Vickers et al., 2008). L. major DHCH1 inhibited pteridine
                                           analogues shown previously inhibit L. major DHFR PTR1, including methotrexate                                            hydrophobic diamino-quinazoline, -pyrimidine -pteridine analogues (compound 34: 2,4-
NIH-PA Author Manuscript




                                           diamino-6-(3,4-dichlorophenoxy)-quinazoline); compound 70; 2,4-diamino-6-benzyl-5-(3-
                                           phenylpropyl)-pyrimidine compound 25 (2,4-diamino-6,7-diisopropylpteridine) (Hardy
                                           et al., 1997, Bello et al., 1994) (tested 50 Î¼M; data shown).

                              Toxicity folate analogues cell lines
                                           5,10 THF inhibited L. major growth EC50 1.1 Â± 0.04 Î¼M (Table 2). Parasites
                                           overexpressing DHCH1 (WT/pXNG4-DHCH1 dhch1âˆ’/+pXNG4-DHCH1) showed 4â€“5
                                           fold resistance (p < 0.0001 p < 0.0003, respectively; Table 2), consistent studies
                                           purified DHCH  Parasites overexpressing FTL (WT/pXNG4-FTL dhch1âˆ’/pXNG4-
                                           FTL) showed 3-fold resistance (p < 0.0001 p < 0.0002, respectively; Table 2), implying
                                           FTL activity act metabolic pass DHCH inhibition. Consistent                                            enzyme inhibition data, DHCH1 FTL overexpressors did resistance                                            methotrexate hydrophobic antifolates tested (compounds 34 70; Table
                                           2). Interestingly, absence DHCH target (dhch1âˆ’/pXNG4-FTL line), growth
                                           inhibited EC50 Î¼M range (Table 2), suggesting 5,10 THF                                            targets Leishmania. FTL excluded sensitive 5,10 THF,                                            bridged structure inhibitor does closely resemble 10-CHO-THF, NIH-PA Author Manuscript




                                           probable target folate-dependent enzymes transporters                                            cell.

                              Discussion
                                           L. major expresses active bifunctional NADP+-dependent DHCH
                                           encoded DHCH1 (Table 1). Previous studies localized DHCH1 protein parasite
                                           cytosol, consistent predicted lack N terminal mitochondrial targeting sequence
                                           NADP dependency DH activity (Vickers et al., 2008). Attempts generate
                                           dhch1âˆ’ null mutants homologous replacement unsuccessful, despite analysis large
                                           number independent events use metabolic supplements shown organisms
                                           rescue DHCH-deficiency. Instead, studies invariably yielded parasites bearing                                            planned replacements, bearing extra copies DHCH1 likely arose                                            aneuploidy. unusual Leishmania phenotype recovery planned replacements, 

                                                Mol Microbiol. Author manuscript; available PMC 2009 June 8.
                            Murta et al.                                                                                             Page 8


                                          retention target gene aneuploidy tetraploidy, widely used                                           indication gene gene essential organism. technical control, chromosomal
                                          dhch1âˆ’ replacements readily obtained ectopic expression DHCH1. Lastly, NIH-PA Author Manuscript




                                          applied plasmid shuffling approach allowed increase number events analyzed
                                          20 fold: 65 classic transfectional approaches, 1,400 negative
                                          selection cell sorting.  unable recover viable dhch1âˆ’ null mutant
                                           virtues potential â€˜plasmid shuffleâ€™ methodology Leishmania discussed
                                          . confident concluding DHCH1 essential gene L.
                                          major circumstances.

                                          Notably, able completely remove DHCH1 following ectopic expression FTL,
                                          provides alternative metabolic route 10-CHO-THF synthesis formate
                                          tetrahydrofolate ligase activity. form â€˜genetic metabolic complementationâ€™ suggests
                                          parasite dependency DHCH1 activity arises provision ultimate
                                          metabolite FTL DHCH1, 10-CHO-THF. Hypothetically, active metabolite
                                          5,10-CH=THF, metabolites interconvert significant rates                                           physiological conditions, precludes measurement individual abundance                                           cell (Brouwer et al., 2007).  known essential role metabolism
                                          5,10-CH=THF, intermediate 10-CHO-THF synthesis, favor
                                          conclusion 10-CHO-THF relevant metabolite.

                                          Interestingly, levels WT FTL activity appear insufficient rescue dhch1âˆ’ parasites,
NIH-PA Author Manuscript




                                          consistent previous finding null mutant ftlâˆ’ parasites phenotypically normal
                                          grown vitro fully infective susceptible mice (Vickers et al., 2008).
                                          Hypothetically, possible elevated FTL synthesis alterations 10-CHO-THF
                                          metabolism bypass requirement DHCH1 circumstances,                                           studies able detect second site mutations including FTL gene
                                          amplification selections forcing loss DHCH1 (S. Murta S. Beverley,
                                          unpublished data).

                              role 10-CHO-THF Trypanosomatid metabolism?
                                          mammals, known roles 10-CHO-THF include provision formyl groups purine
                                          biosynthesis, intermediate C1-THF interconversions involved amino acid metabolism
                                          (glycine, methionine, histidine, serine), production fMet- tRNAMet                                           mitochondrion (Appling, 1991, Christensen & MacKenzie, 2006).  Leishmania                                           known purine auxotrophs genome lacks purine biosynthetic enzymes
                                          glycinamide ribonucleotide (GAR) phosphoribosylaminoimidazolecarboxamide
                                          (AICAR) transformylases (EC 2.1.1.2 2.1.2.3 respectively) (Carter et al., 2008). Similarly,
                                          studies established Leishmania require amino acids arising NIH-PA Author Manuscript




                                          C1-pathway normal growth (Scott et al., 2008, Vickers et al., 2008).                                           conditions tested, formylation initiator Met-tRNAMet currently stands                                           candidate essential metabolic role. discussed earlier, extent fMet- tRNAMet
                                          synthesis required matter debate, differences seen studies                                           species eukaryotes prokaryotes.  conclusion                                           Leishmania require fMet-tRNAMet consistent finding related
                                          trypanosomatid parasite T. brucei requires formylated initiator methionyl-tRNAMet                                           mitochondrial protein synthesis survival (Tan et al., 2002, Charriere et al., 2005).                                           suggest cytoplasmic 10-CHO-THF arising FTL DHCH1 activity
                                          cytosol transported mitochondrion. generally thought                                           metabolites reduced folates principal route communication cytosolic-
                                          mitochondrial C1-dependent pathways mammalian cells (Appling, 1991), studies




                                               Mol Microbiol. Author manuscript; available PMC 2009 June 8.
                            Murta et al.                                                                                                   Page 9


                                          point trafficking C1 tetrahydrofolates cytosol mitochondrion plants
                                          (Prabhu et al., 1998, Hanson et al., 2000).
NIH-PA Author Manuscript




                                          interpretations rest strength accuracy current genome-based models
                                          Trypanosomatid metabolomes. Given substantial number hypothetical proteins                                           unknown function encoded Trypanosomatid genomes (Peacock et al., 2007, Ivens et al.,
                                          2005, El-Sayed et al., 2005, Berriman et al., 2005), exclude possibility                                           Leishmania possess novel essential pathways require 10-CHO-THF.  L.
                                          major genome predicts highly degenerate pseudogene (pseDHCH2) DHCH2-related
                                          sequences completely absent L. braziliensis African trypanosome genomes
                                          (Peacock et al., 2007, Ivens et al., 2005, El-Sayed et al., 2005, Berriman et al., 2005). contrast,
                                          seemingly intact DHCH2s occur L. infantum, L. mexicana, Crithidia fasciculata                                           Trypanosoma cruzi, predicted proteins conservation DHCH active site residues
                                          (Vickers et al., 2008). Interestingly, GFP tagged LiDHCH2 localized mitochondrion
                                          expressed L. donovani (Vickers et al., 2008), able                                           demonstrate DHCH activity associated expression WT LiDHCH2 (data                                           shown). Potentially occurrence catalytically active DHCH2 signify increased
                                          importance mitochondrial 10-CHO-THF synthesis trypanosomatid species.                                           future, direct studies mitochondrial fMet-tRNAMet synthesis mediated FMT                                           DHCH2 enzymatically active trypanosomatids possess test                                           hypotheses.
NIH-PA Author Manuscript




                              Plasmid segregation shuffling improved test gene function
                                          Currently, standard approach determining gene essential Leishmania                                           inability delete chromosomal alleles homologous gene replacement (Cruz et al.,
                                          1991, Barrett et al., 1999). Fortunately, studies facilitated fact homologous
                                          recombination occurs far frequently non-homologous insertions trypanosomatids
                                          (Beverley, 2003, Clayton, 1999). Ignoring technical failures, general experience                                           investigators attempts delete essential genes Leishmania yield parasites
                                          bearing planned allelic replacements containing additional gene copies arise                                           aneuploidy polyploidy (Cruz et al., 1993, Dumas et al., 1997, Ilgoutz et al., 1999b, Vergnes
                                          et al., 2005, Balana-Fouce et al., 2008). considered diagnostic criterion,
                                          especially accompanied successful replacement presence ectopic gene.

                                          challenge gene replacement-based approach relative inefficiency                                           transfection (10âˆ’4 , limiting number events scored. example,                                           analyzed 65 events targeting copy DHCH1, number exceeding typically
                                          reported tests Leishmania gene function. factors impinging replacement-based
                                          approaches include transfection efficiencies vary greatly depending locus NIH-PA Author Manuscript




                                          targeting construct used (Papadopoulou & Dumas, 1997), survivors emerge
                                          mutations unrelated targeted gene (unpublished data). contrast, plasmid
                                          shuffling approach, functional tests arise segregation ectopically expressed gene
                                          borne plasmid bearing positive (GFP) negative (TK) markers, line previously
                                          engineered lack gene (Fig. 5). Following brief period culture allow
                                          segregation episomal vector, large number candidate â€˜segregantsâ€™ obtained
                                          appropriate manipulations GFP TK markers, rapidly tested. allowed
                                          rapidly score ~1400 segregants DHCH1, 20 times number achieved
                                          traditional methods, necessary tested. believe
                                          plasmid segregation method provides significant improvement tests essential
                                          gene function Leishmania, established yeast Saccharomyces cerevisiae
                                          (Forsburg, 2001). future envisage number applications based                                           approach â€˜plasmid shufflingâ€™.


                                                Mol Microbiol. Author manuscript; available PMC 2009 June 8.
                            Murta et al.                                                                                             Page 10


                              DHCH1 10-CHO-THF metabolism target anti-parasitic chemotherapy
                                          L. major folate metabolism shows differences human hosts, including
                                          bifunctional dihydrofolate reductase-thymidylate synthase (DHFR-TS) (Coderre et al.,
NIH-PA Author Manuscript




                                          1983), novel pteridine reductase (PTR1) (Bello et al., 1994), large complex family                                           folate biopterin transporters (Ouellette et al., 2002), cytosolic mitochondrial
                                          synthesis 10-CHO-THF (Vickers et al., 2008),  factors contribute                                           profound differences antifolate sensitivity; example, relative insensitivity PTR1
                                          antifolates ability act metabolic bypass DHFR inhibition accounts
                                          relative lack efficacy drugs Leishmania (Bello et al., 1994, Nare et
                                          al., 1997).

                                          folate metabolizing enzymes essential Leishmania (DHFR-TS,
                                          folylpolyglutamyl-synthase) (Cruz & Beverley, 1990, El Fadili et al., 2002), tested
                                          appear largely wholly dispensable growth virulence, including methylene
                                          tetrahydrofolate reductase glycine cleavage complex (Scott et al., 2008, Vickers et
                                          al., 2006). reflect ability parasite salvage sufficient quantities                                           C1-THF dependent metabolites amino acids purines (Carter et al., 2008, Scott et
                                          al., 1987), particularly mammalian stages parasite reside                                           phagolysosomes postulated rich free amino acids (McConville et al., 2007).
                                          contrast, unable rescue requirement DHCH1 wide array                                           metabolites known postulated rescue DHCH deficiency. reflect factors
NIH-PA Author Manuscript




                                          including deficiency non-salvageable metabolite, conclusion consistent                                           essential requirement mitochondrial fMet-tRNAMet.

                                          parasite enzyme good drug target essential parasite survival,
                                          dispensable, absent, substantially different host (Fairlamb, 2002). mammals
                                          cystosolic mitochondrial forms DHCH (MTHFD1 MTHFD2 respectively)
                                          essential early development (Di Pietro et al., 2002, Brody et al., 2002, Parle-McDermott
                                          et al., 2005).  human fibroblasts lacking enzyme viable, purine                                           glycine auxotrophs (Christensen et al., 2005b, Patel et al., 2003), 10-CHO-THF
                                          metabolism dispensable yeast S. cerevisiae grown rich media (West et al.,
                                          1996). suggests adult tissues human host dependent DHCH
                                          activity Leishmania. contrast, 10-CHO-THF pathway simplified parasitic
                                          protozoans, species synthesize single cytosolic DHCH FTL (L. major, L.
                                          braziliensis), synthesize just cytosolic DHCH (African trypanosomes) (Vickers
                                          et al., 2008). Preliminary genomic analysis suggest like African trypanosomes, malaria
                                          parasite P. falciparum possess single route 10-CHO-THF synthesis, bifunctional
                                          DHCH (Nzila et al., 2005). data suggest relative simplicity 10-CHO-THF
                                          pathway parasitic protozoa relative human host render sensitive NIH-PA Author Manuscript




                                          chemotherapeutic interventions.

                                          DHCH inhibitors developed, L. major DHCH1 activity promastigote
                                          growth vitro sensitive substrate analog 5,10 THF (Temple et al., 1982).                                           specificity inhibitor supported findings DHCH1 overexpressors                                           susceptible, fails inhibit DHFR FTL enzymatic activity.  expression
                                          FTL did completely overcome 5,10 THF inhibition suggesting                                           targets DHCH1.

                                          Consistent genetic studies  DHCH inhibitors little activity toxicity
                                          mammalian cells vitro, mouse cancer models, concentrations 10 Î¼M
                                          (Tonkinson et al., 1998, Temple et al., 1982). preliminary studies modest activity
                                          5,10 THF Leishmania amastigotes macrophages (EC50 ~ 5 Î¼M),                                           host cell toxicity seen 10 Î¼M (S. Hickerson S. Beverley, unpublished data).


                                               Mol Microbiol. Author manuscript; available PMC 2009 June 8.
                            Murta et al.                                                                                              Page 11


                                          results encouraging 5,10 THF actually selective host                                           parasite enzymes (Ki = 18 v. 105 nM respectively; (Schmidt et al., 2000) Fig. 6). highly
                                          conserved, numerous differences Leishmania DHCH1 human cytosolic NIH-PA Author Manuscript




                                          mitochondrial DHCHs (Fig. S2) exploited design selective potent
                                          inhibitors. DHCH inhibitors received high priority cancer chemotherapy programs
                                          poor efficacy ones tested, number antifolates targeting 10-
                                          CHO-THF utilizing enzymes GAR transformylase developed (Zhang et
                                          al., 2003). Possibly, similar pharmacophores hold promise targeting 10-CHO-THF
                                          metabolism Leishmania Trypanosomatids.

                              EXPERIMENTAL PROCEDURES
                              Reagents
                                          (6-R,S)-Tetrahydrofolate (THF) 5,10-CH=THF obtained Schircks Laboratories
                                          (Jona, Switzerland). (2S)-2-[[4-[(6aR)-3-amino-1,9-dioxo-5,6,6a,7-tetrahydro-4H- imidazo
                                          [3,4-f]pteridin-8-yl]benzoyl]amino]pentanedioic acid (5,10 THF) custom
                                          synthesized SAFC Pharma, division Sigma-Aldrich Corporation, according                                           method Temple et al. (Temple et al., 1982); compound 96.2  pure high-
                                          performance liquid chromatography. Methotrexate compound 25 (2,4-Diamino-6,7-
                                          diisopropylpteridine) purchased Sigma, folate analogues compound 34 (2,4-
                                          diamino-6-(3,4-dichlorophenoxy)-quinazoline) compound 70 (2,4-diamino-6-benzyl-5-
NIH-PA Author Manuscript




                                          (3-phenylpropyl)-pyrimidine) described (Hardy et al., 1997). Hygromycin B (HYG)
                                          purchased Calbiochem (EMD Biosciences, San Diego, CA) nourseothricin
                                          (SAT) Werner BioAgents (Jena, Germany). chemicals reagents                                           analytical grade purchased Sigma-Aldrich.

                              Parasite growth drug inhibition
                                          studies used derivatives L. major clone Friedlin V1 promastigotes, grown 27Â°C                                           M199 medium  Biologicals) supplemented 40 mM 4-(2-hydroxyethyl)-1-
                                          piperazineethanesulfonic acid (HEPES) pH 7.4, 50 Î¼M adenosine, 1 Î¼g mlâˆ’1 biotin, 5 Î¼g
                                          mlâˆ’1 hemin, 2 Î¼g mlâˆ’1 biopterin 10   (v/v) heat-inactivated fetal calf serum. Growth                                           determined seeding parasites 5 Ã— 105 cells mlâˆ’1 various concentrations drug                                           counting cells using model Z1 Coulter counter cultures reached late-log phase.                                           EC50 value concentration drug required decrease growth 50 .

                                          Cloning L. major DHCH1 DHCH1 coding sequence amplified                                           recombinant Pfu DNA polymerase (Stratagene) using L. major genomic DNA template,
                                          prepared LiCl mini-prep method (Medina-Acosta & Cross, 1993), using primers
NIH-PA Author Manuscript




                                          SMB3528 SMB3529, added 5â€² NdeI 3â€² BamHI sites, respectively. amplified
                                          product cloned pCR.blunt (Invitrogen), yielding pCR.blunt. DHCH1 (B6255)                                           NdeI-BamHI fragment transferred corresponding sites pET15b (Novagen), yielding
                                          pET15b-LmjDHCH1 (B6026).

                              Expression, purification enzymatic assays recombinant L. major DHCH1
                                          Protein expressed E. coli pET15b-LmjDHCH1 purified metal-affinity
                                          chromatography, described supplemental methods. purification storage
                                          protein inclusion 10  glycerol buffers required prevent loss                                           activity. manner, enzyme flash-frozen loss activity. DHCH
                                          activities measured spectrophotometrically, using temperature-controlled Beckman
                                          DU-640 spectrophotometer, essentially described Tan et al. (Tan et al., 1977) following
                                          formation 5,10-CH=THF 5,10-CH2-THF (DH activity) conversion                                           5,10-CH=THF 10-CHO-THF (CH activity). 5,10-CH2-THF dehydrogenase assays 
                                               Mol Microbiol. Author manuscript; available PMC 2009 June 8.
                            Murta et al.                                                                                           Page 12


                                          carried 0.5 ml volume 27Â°C contained 25 mM MOPS, pH 7.3, 250 Î¼M THF,
                                          2.5 mM formaldehyde, 1 mM NADP+ 30 mM 2-mercaptoethanol. Assays                                           preincubated 5 min allow formation 5,10-CH2-THF reactions initiated NIH-PA Author Manuscript




                                          addition enzyme. reactions stopped 5 min addition equal
                                          volume 1 M HCl 5,10-CH=THF produced quantified 350 nm, using extinction
                                          coefficient 24.9 mMâˆ’1 cmâˆ’1. DH activity expressed Î¼moles 5,10-CH=THF produced
                                          minute. Formaldehyde stocks freshly-prepared paraformaldehyde, THF
                                          dissolved just use 250 mM triethanolamine-Cl, pH 7, 40 mM 2-mercaptoethanol.
                                          Cyclohydrolase activity measured 0.5 ml assays 27Â°C containing 25 mM MOPS, pH
                                          7.3, 30 mM 2-mercaptoethanol 50 Î¼M 5, 10-CH=THF. hydrolysis 5,10-CH=THF
                                          followed 355 nm, non-enzymatic rate subtracted.

                                          Enzyme inhibition measured using dehydrogenase assay, stocks hydrophobic
                                          diaminoquinazolines diaminopteridines dissolved DMSO, 5,10 THF dissolved
                                          250 mM triethanolamine-Cl, pH 7, 40 mM 2-mercaptoethanol, THF, stored                                           âˆ’80 Â°C. 5,10 THF custom synthesized Sigma-Aldrich Chemical Pvt. 
                                          (Bangalore, India); authenticity procuct supported infrared spectroscopy                                           proton NMR estimated greater 96  pure. Data 5,10 THF
                                          inhibition assays fitted competitive, non-competitive, uncompetitive mixed
                                          inhibition models non-linear regression using Sigmaplot. DHFR activity                                           bifunctional L. major DHFR-TS measured described (Hardy et al., 1997). Activity NIH-PA Author Manuscript




                                          drug assays expressed percentage drug DMSO control.

                              DHCH1 replacement constructs
                                          Fusion PCR (Szewczyk et al., 2006) used generate deletion constructs,                                           contained puromycin (PAC) hygromycin (HYG) drug-resistance cassettes                                           5â€² 3â€² LmjDHCH1 flanking sequences (Szewczyk et al., 2006). Briefly, flanking
                                          sequences drug resistance cassettes amplified separately PCR using primers                                           produce overlapping ends. 5â€² 3â€² LmjDHCH1 flanking sequences (743 726 bp),
                                          amplified using primers SMB2772/2656 2657/2773 added SphI                                           BamHI site, respectively. PAC HYG drug-resistance cassettes (600 1026 bp)                                           amplified using primers SMB2557/2558 SMB2561/2562, respectively added                                           linker sequence. deletion construct mixing purified PCR products
                                          flanking sequences drug-resistance cassette using products templates
                                          second round PCR. PCR reactions generate PAC HYG constructs
                                          used external primers SMB2772 2773, fused flanking sequences                                           correct drug resistance cassette. deletion constructs cloned pGEM-
                                          T (Promega), yielding pGEM-T.5â€². PAC.3â€². LmjDHCH1 (B4827) pGEM-T.5â€². HYG.3â€².
                                          LmjDHCH1 (B4827). sequences constructs confirmed restriction
NIH-PA Author Manuscript




                                          mapping sequencing.

                              DHCH1 replacement transfections
                                          DHCH1-targeting fragments digested SphI BamHI, linear targeting
                                          fragments containing PAC (2.1 kb) HYG (2.5 kb) transfected separately wild-type
                                          (WT) L. major FV1 promastigotes described (Robinson & Beverley, 2003). Heterozygous
                                          clones, DHCH1/Î”dhch1::PAC DHCH1/Î”dhch1::HYG (referred PAC/+ HYG/+),                                           isolated plating semisolid M199 medium containing 30 Î¼g mlâˆ’1 puromycin 50 Î¼g
                                          mlâˆ’1 hygromycin B, respectively. Heterozygous PAC/+ HYG/+ clones transfected
                                          deletion constructs containing HYG PAC cassettes. parasites plated                                           semisolid M199 medium containing 30 Î¼g mlâˆ’1 puromycin 50 Î¼g mlâˆ’1 hygromycin.                                           attempts rescue growth DHCH1âˆ’/âˆ’ homozygotes different mixtures                                           different supplements added plating medium. basic supplements  glycine


                                               Mol Microbiol. Author manuscript; available PMC 2009 June 8.
                            Murta et al.                                                                                                                Page 13


                                           (1 mg mlâˆ’1), serine (0.1 mg mlâˆ’1), formate (5 mM), THF (5 Î¼M), thymidine (10 Î¼g mlâˆ’1)                                            folinic acid (10 Î¼g mlâˆ’1). Additional supplements added basic mixture                                            plates,  5,10-CH=THF (10 Î¼M), 10-formylfolic acid 10-CHOFA (10 Î¼M) 
NIH-PA Author Manuscript




                                           alternatively, uridine (0.1 mg mlâˆ’1) sodium pyruvate (1 mM). DNA contents                                            permeabilized RNAse treated cells measured propidium iodide staining using flow
                                           cytometry (Cruz et al., 1993).

                              PCR primers assessing chromosomal DHCH1 PAC HYG replacements
                                           Generation planned PAC HYG replacements confirmed PCR, using primer
                                           located 5â€² (SMB2731) 3â€² (SMB2771) DHCH1 ORF targeting fragment primer
                                           located PAC HYG genes (SMB2557/2558 SMB2561/2562). loss                                            DHCH1 ORFs confirmed using primers specific chromosomal DHCH1 allele
                                           (SMB3125/3126) using forward primer located chromosome 5â€² (SBM2731)                                            DHCH1 ORF targeting fragment reverse primer located DHCH1 gene
                                           (SMB3126).

                              pXNG4 expression constructs
                                           DHCH1 FTL ORFs amplified primers (SMB3125/3126 SMB3123/3124,
                                           respectively) L. major genomic DNA, adding flanking BglII sites, CCACC sequence
                                           preceding initiation codon. DHCH1 FTL ORFs inserted pGEM-T
NIH-PA Author Manuscript




                                           (Promega) yielding pGEM-DHCH1 (B6029) pGEM-FTL (B6030); DHCH1                                            FTL ORFs extracted BglII digestion inserted BglII site pXNG4
                                           (B5840) create pXNG4-DHCH1 (B6031) pXNG4-FTL (B6032).

                                           plasmids transfected wild-type L. major FV1, heterozygote lines
                                           (DHCH1/Î”dhch1::PAC DHCH1/Î” dhch1:: HYG) transformants isolated 
                                           using plating media containing 100 Î¼g mlâˆ’1 nourseothricin 30 Î¼g mlâˆ’1 puromycin
                                           50 Î¼g mlâˆ’1 hygromycin. presence plasmid confirmed PCR FACS analysis
                                           presence SAT GFP markers, respectively. colonies expressing FTL
                                           DHCH1 submitted second replacement using PAC HYG targeting
                                           fragments. parasites isolated plating semi-solid M199 media containing 100
                                           Î¼g mlâˆ’1 nourseothricin, 30 Î¼g mlâˆ’1 puromycin 50 Î¼g mlâˆ’1 hygromycin.

                              Single-cell sorting
                                           Prior flow cytometry, dhch1âˆ’/pXNG4-DHCH1 lines incubated 50 Î¼g mlâˆ’1
                                           ganciclovir M199 media 24 h. Single cells sorting performed based                                            GFP fluorescence described Results. Cells resuspended phosphate-buffered
                                           saline, filtered CellTrics 50 Î¼m filters remove clumps (Partec). Single cells
NIH-PA Author Manuscript




                                           recovered using Dako MoFlo high-speed cell sorter placed individual
                                           wells 96 plates, containing 150 Î¼l M199 medium. Plates incubated 27Â° C
                                           1â€“2 weeks parasite growth scored.

                              Supplementary Material
                                           Refer Web version PubMed Central supplementary material.


                              Acknowledgments
                                           thank  Hanson M. Ouellette discussions. thank Sushil Rajan Sigma-Aldrich Chemical Pvt. 
                                           custom synthesis 5,10 THF. Single-cell sorting assistance staff high-speed
                                           sorter core, Alvin J. Siteman Cancer Center, Washington University Medical School. Siteman Cancer Center                                            supported NCI Cancer Center Support Grant #P30 CA91842. work supported National Institutes




                                                 Mol Microbiol. Author manuscript; available PMC 2009 June 8.
                            Murta et al.                                                                                                      Page 14

                                          Health Grant AI21903  S.M.B.); Brazilian agencies: CNPq FAPEMIG  S.M.F.M.) European
                                          Molecular Biology Organization long term fellowship ALTF 106â€“2005  T. V.).
NIH-PA Author Manuscript




                              Abbreviations
                                          THF
                                                         tetrahydrofolate

                                          10-CHO-THF
                                                   10-formyl tetrahydrofolate

                                          5,10-CH=THF
                                                    5,10-methenyl-tetrahydrofolate

                                          5,10-CH2-THF
                                                     5,10-methylene-tetrahydrofolate

                                          DHCH1
                                                         gene encoding Leishmania cytosolic methenyltetrahydrofolate cyclohydrolase/
                                                         5,10-methylenetetrahydrofolate dehydrogenase

                                          FTL
                                                         formate-tetrahydrofolate ligase
NIH-PA Author Manuscript




                                          DHFR-TS
                                                         dihydrofolate reductase-thymidylate synthase

                                          WT
                                                         wild-type

                                          DH
                                                         dehydrogenase

                                          CH
                                                         cyclohydrolase

                              References
                                          Allaire M, Li Y, MacKenzie  Cygler M. 3-D structure folate-dependent dehydrogenase/
                                            cyclohydrolase bifunctional enzyme 1.5 resolution. Structure 1998;6:173â€“182. [PubMed:
                                            9519408]
                                          Appling DR. Compartmentation folate-mediated carbon metabolism eukaryotes. Faseb J
                                            1991;5:2645â€“2651. [PubMed: 1916088]
NIH-PA Author Manuscript




                                          Balana-Fouce R, Garcia-Estrada C, Perez-Pertejo Y, Reguera RM. Gene disruption DNA
                                            topoisomerase IB small subunit induces non-viable phenotype hemoflagellate Leishmania
                                            major. BMC Microbiol 2008;8:113. [PubMed: 18611247]
                                          Barrett MP, Mottram JC, Coombs GH. Recent advances identifying validating drug targets                                             trypanosomes leishmanias. Trends Microbiol 1999;7:82â€“88. [PubMed: 10081086]
                                          Bello AR, Nare B, Freedman D, Hardy L, Beverley SM. PTR1: reductase mediating salvage oxidized
                                            pteridines methotrexate resistance protozoan parasite Leishmania major. Proc Natl Acad
                                            Sci U S 1994;91:11442â€“11446. [PubMed: 7972081]
                                          Berriman M, Ghedin E, Hertz-Fowler C, Blandin G, Renauld H, Bartholomeu DC, Lennard NJ, Caler E,
                                            Hamlin NE, Haas B, Bohme U, Hannick L, Aslett MA, Shallom J, Marcello L, Hou L, Wickstead B,
                                            Alsmark UC, Arrowsmith C, Atkin RJ, Barron AJ, Bringaud F, Brooks K, Carrington M, Cherevach
                                             Chillingworth TJ, Churcher C, Clark LN, Corton CH, Cronin  Davies RM, Doggett J, Djikeng 
                                            Feldblyum T, Field MC, Fraser  Goodhead  Hance  Harper D, Harris BR, Hauser H, Hostetler
                                            J, Ivens  Jagels K, Johnson D, Johnson J, Jones K, Kerhornou AX, Koo H, Larke N, Landfear S,


                                                Mol Microbiol. Author manuscript; available PMC 2009 June 8.
                            Murta et al.                                                                                                    Page 15


                                            Larkin C, Leech V, Line  Lord  Macleod  Mooney PJ, Moule S, Martin DM, Morgan GW,
                                            Mungall K, Norbertczak H, Ormond D, Pai G, Peacock CS, Peterson J, Quail MA, Rabbinowitsch E,
                                            Rajandream MA, Reitter C, Salzberg SL, Sanders M, Schobel S, Sharp S, Simmonds M, Simpson AJ,
NIH-PA Author Manuscript




                                            Tallon L, Turner CM, Tait  Tivey AR, Van Aken S, Walker D, Wanless D, Wang S, White B, White
                                            O, Whitehead S, Woodward J, Wortman J, Adams MD, Embley TM, Gull K, Ullu E, Barry JD,
                                            Fairlamb AH, Opperdoes F, Barrell BG, Donelson JE, Hall N, Fraser CM, et al. genome                                             African trypanosome Trypanosoma brucei. Science 2005;309:416â€“422. [PubMed: 16020726]
                                          Beverley SM. Protozomics: trypanosomatid parasite genetics comes age. Nat Rev Genet 2003;4:11â€“
                                            19. [PubMed: 12509749]
                                          Brody LC, Conley M, Cox C, Kirke PN, McKeever MP, Mills JL, Molloy  Oâ€™Leary VB, Parle-
                                            McDermott  Scott JM, Swanson DA. polymorphism, R653Q, trifunctional enzyme
                                            methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase/
                                            formyltetrahydrofolate synthetase maternal genetic risk factor neural tube defects: report                                             Birth Defects Research Group. J Hum Genet 2002;71:1207â€“1215. [PubMed: 12384833]
                                          Brouwer VD, Zhang GF, Storozhenko S, Straeten DV, Lambert  pH stability individual folates
                                            critical sample preparation steps prevision analysis plant folates. Phytochem Anal
                                            2007;18:496â€“508. [PubMed: 17624887]
                                          Carter NS, Yates P, Arendt CS, Boitz JM, Ullman B. Purine pyrimidine metabolism                                               Leishmania. Adv Exp Med Biol 2008;625:141â€“154. [PubMed: 18365665]
                                          Cavazzuti  Paglietti G, Hunter WN, Gamarro F, Piras S, Loriga M, Allecca S, Corona P, McLuskey
                                              K, Tulloch L, Gibellini F, Ferrari S, Costi MP. Discovery potent pteridine reductase inhibitors                                               guide antiparasite drug development. Proc Natl Acad Sci U S 2008;105:1448â€“1453. [PubMed:
NIH-PA Author Manuscript




                                              18245389]
                                          Charriere F, Tan TH, Schneider  Mitochondrial initiation factor 2 Trypanosoma brucei binds
                                              imported formylated elongator-type tRNA(Met). J Biol Chem 2005;280:15659â€“15665. [PubMed:
                                              15731104]
                                          Christensen KE, MacKenzie  Mitochondrial carbon metabolism adapted specific needs
                                              yeast, plants mammals. Bioessays 2006;28:595â€“605. [PubMed: 16700064]
                                          Christensen KE, Mackenzie  Chapter 14. Mitochondrial methylenetetrahydrofolate dehydrogenase,
                                              methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetases. Vitam Horm
                                              2008;79:393â€“410. [PubMed: 18804703]
                                          Christensen KE  Mirza  Berghuis  Mackenzie  Magnesium phosphate ions enable NAD
                                              binding methylenetetrahydrofolate dehydrogenase-methenyltetrahydrofolate cyclohydrolase. J
                                              Biol Chem 2005a;280:34316â€“34323. [PubMed: 16100107]
                                          Christensen KE, Patel H, Kuzmanov U, Mejia NR, MacKenzie  Disruption mthfd1 gene reveals
                                              monofunctional 10-formyltetrahydrofolate synthetase mammalian mitochondria. J Biol Chem
                                              2005b;280:7597â€“7602. [PubMed: 15611115]
                                          Clayton CE. Genetic manipulation kinetoplastida. Parasitol Today 1999;15:372â€“378. [PubMed:
                                              10461166]
                                          Coderre JA, Beverley SM, Schimke RT, Santi DV. Overproduction bifunctional thymidylate
NIH-PA Author Manuscript




                                              synthetase-dihydrofolate reductase DNA amplification methotrexate-resistant Leishmania
                                              tropica. Proc Natl Acad Sci U S 1983;80:2132â€“2136. [PubMed: 6572966]
                                          Cruz  Beverley SM. Gene replacement parasitic protozoa. Nature 1990;348:171â€“173. [PubMed:
                                              2234081]
                                          Cruz  Coburn C, Beverley SM. Double targeted gene replacement creating null mutants.
                                              Proceedings National Academy Sciences 1991;88:7170â€“7174.
                                          Cruz AK, Titus R, Beverley SM. Plasticity chromosome number testing essential genes                                               Leishmania targeting. Proc Natl Acad Sci U S 1993;90:1599â€“1603. [PubMed: 8381972]
                                          Di Pietro E, Sirois J, Tremblay ML, MacKenzie  Mitochondrial NAD-dependent
                                              methylenetetrahydrofolate dehydrogenase-methenyltetrahydrofolate cyclohydrolase essential                                               embryonic development. Mol Cell Biol 2002;22:4158â€“4166. [PubMed: 12024029]
                                          Dumas C, Ouellette M, Tovar J, Cunningham ML, Fairlamb AH, Tamar S, Olivier M, Papadopoulou B.
                                              Disruption trypanothione reductase gene Leishmania decreases ability survive
                                              oxidative stress macrophages. EMBO J 1997;16:2590â€“2598. [PubMed: 9184206]


                                                Mol Microbiol. Author manuscript; available PMC 2009 June 8.
                            Murta et al.                                                                                                  Page 16


                                          El-Sayed NM, Myler PJ, Blandin G, Berriman M, Crabtree J, Aggarwal G, Caler E, Renauld H, Worthey
                                              EA, Hertz-Fowler C, Ghedin E, Peacock C, Bartholomeu DC, Haas BJ, Tran  Wortman JR,
                                              Alsmark UC, Angiuoli S, Anupama  Badger J, Bringaud F, Cadag E, Carlton JM, Cerqueira GC,
NIH-PA Author Manuscript




                                              Creasy T, Delcher AL, Djikeng  Embley TM, Hauser C, Ivens AC, Kummerfeld SK, Pereira-Leal
                                              JB, Nilsson D, Peterson J, Salzberg SL, Shallom J, Silva JC, Sundaram J, Westenberger S, White O,
                                              Melville SE, Donelson JE, Andersson B, Stuart KD, Hall N. Comparative genomics                                               trypanosomatid parasitic protozoa. Science 2005;309:404â€“409. [PubMed: 16020724]
                                          El Fadili  Kundig C, Ouellette M. Characterization folylpolyglutamate synthetase gene                                               polyglutamylation folates protozoan parasite Leishmania. Mol Biochem Parasitol
                                              2002;124:63â€“71. [PubMed: 12387851]
                                          Fairlamb AH. Metabolic pathway analysis trypanosomes malaria parasites. Philos Trans R Soc
                                              Lond B Biol Sci 2002;357:101â€“107. [PubMed: 11839187]
                                          Forsburg SL. art design genetic screens: yeast. Nat Rev Genet 2001;2:659â€“668. [PubMed:
                                              11533715]
                                          Hanson AD, Gage DA, Shachar-Hill Y. Plant carbon metabolism engineering. Trends Plant
                                              Sci 2000;5:206â€“213. [PubMed: 10785666]
                                          Hanson AD, Roje S. Carbon Metabolism Higher Plants. Annu Rev Plant Physiol Plant Mol Biol
                                              2001;52:119â€“137. [PubMed: 11337394]
                                          Hardy LW, Matthews W, Nare B, Beverley SM. Biochemical genetic tests inhibitors                                               Leishmania pteridine pathways. Exp Parasitol 1997;87:157â€“169. [PubMed: 9371081]
                                          Hatefi Y, Osborn MJ, Kay LD, Huennekens FM. Hydroxymethyl tetrahydrofolic dehydrogenase. J Biol
NIH-PA Author Manuscript




                                              Chem 1957;227:637â€“647. [PubMed: 13462986]
                                          Ilgoutz SC, Mullin KA, Southwell BR, McConville MJ. Glycosylphosphatidylinositol biosynthetic
                                              enzymes localized stable tubular subcompartment endoplasmic reticulum                                               Leishmania mexicana. EMBO J 1999a;18:3643â€“3654. [PubMed: 10393180]
                                          Ilgoutz SC, Zawadzki JL, Ralton JE, McConville MJ. Evidence free GPI glycolipids essential
                                              growth Leishmania mexicana. EMBO J 1999b;18:2746â€“2755. [PubMed: 10329621]
                                          Ivens AC, Peacock CS, Worthey EA, Murphy L, Aggarwal G, Berriman M, Sisk E, Rajandream MA,
                                              Adlem E, Aert R, Anupama  Apostolou  Attipoe P, Bason N, Bauser C, Beck  Beverley SM,
                                              Bianchettin G, Borzym K, Bothe G, Bruschi CV, Collins M, Cadag E, Ciarloni L, Clayton C, Coulson
                                              RM, Cronin  Cruz AK, Davies RM, Gaudenzi J, Dobson  Duesterhoeft  Fazelina G,
                                              Fosker N, Frasch AC, Fraser  Fuchs M, Gabel C, Goble  Goffeau  Harris D, Hertz-Fowler C,
                                              Hilbert H, Horn D, Huang Y, Klages S, Knights  Kube M, Larke N, Litvin L, Lord  Louie T,
                                              Marra M, Masuy D, Matthews K, Michaeli S, Mottram JC, Muller-Auer S, Munden H, Nelson S,
                                              Norbertczak H, Oliver K, Oâ€™Neil S, Pentony M, Pohl TM, Price C, Purnelle B, Quail MA,
                                              Rabbinowitsch E, Reinhardt R, Rieger M, Rinta J, Robben J, Robertson L, Ruiz JC, Rutter S, Saunders
                                              D, Schafer M, Schein J, Schwartz DC, Seeger K, Seyler  Sharp S, Shin H, Sivam D, Squares R,
                                              Squares S, Tosato V, Vogt C, Volckaert G, Wambutt R, Warren T, Wedler H, Woodward J, Zhou S,
                                              Zimmermann W, Smith DF, Blackwell JM, Stuart KD, Barrell B, et al. genome                                               kinetoplastid parasite, Leishmania major. Science 2005;309:436â€“442. [PubMed: 16020728]
NIH-PA Author Manuscript




                                          Kedzierski L, Zhu Y, Handman E. Leishmania vaccines: progress problems. Parasitology 2006;133
                                              (Suppl):S87â€“112. [PubMed: 17274851]
                                          Kozak M. Comparison initiation protein synthesis procaryotes, eucaryotes, organelles.
                                              Microbiol Rev 1983;47:1â€“45. [PubMed: 6343825]
                                          Li Y, Holmes WB, Appling DR, RajBhandary UL. Initiation protein synthesis Saccharomyces
                                              cerevisiae mitochondria formylation initiator tRNA. J Bacteriol 2000;182:2886â€“2892.
                                              [PubMed: 10781559]
                                          McConville MJ, Souza D, Saunders E, Likic VA, Naderer T. Living phagolysosome; metabolism
                                              Leishmania amastigotes. Trends Parasitol 2007;23:368â€“375. [PubMed: 17606406]
                                          Medina-Acosta E, Cross GA. Rapid isolation DNA trypanosomatid protozoa using simple
                                              â€˜mini-prepâ€™ procedure. Mol Biochem Parasitol 1993;59:327â€“329. [PubMed: 8341329]
                                          Mejia NR, MacKenzie  NAD-dependent methylenetetrahydrofolate dehydrogenase-
                                              methenyltetrahydrofolate cyclohydrolase transformed cells mitochondrial enzyme. Biochem
                                              Biophys Res Commun 1988;155:1â€“6. [PubMed: 3261979]



                                                Mol Microbiol. Author manuscript; available PMC 2009 June 8.
                            Murta et al.                                                                                                   Page 17


                                          Mishra J, Saxena  Singh S. Chemotherapy leishmaniasis: past, present future. Curr Med Chem
                                              2007;14:1153â€“1169. [PubMed: 17456028]
                                          Moore MR, Oâ€™Brien  Ljungdahl LG. Purification characterization nicotinamide adenine
NIH-PA Author Manuscript




                                              dinucleotide-dependent methylenetetrahydrofolate dehydrogenase Clostridium
                                              formicoaceticum. J Biol Chem 1974;249:5250â€“5253. [PubMed: 4153026]
                                          Nare B, Luba J, Hardy LW, Beverley S. New approaches Leishmania chemotherapy: pteridine
                                              reductase 1 (PTR1) target modulator antifolate sensitivity. Parasitology 1997;114:S101â€“
                                              110. [PubMed: 9309772]
                                          Newton DT, Creuzenet C, Mangroo D. Formylation essential initiation protein synthesis                                               eubacteria. J Biol Chem 1999;274:22143â€“22146. [PubMed: 10428776]
                                          Nour JM, Rabinowitz JC. Isolation, characterization, structural organization 10-
                                              formyltetrahydrofolate synthetase spinach leaves. J Biol Chem 1991;266:18363â€“18369.
                                              [PubMed: 1917961]
                                          Nzila  Ward SA, Marsh K, Sims PF, Hyde JE. Comparative folate metabolism humans malaria
                                              parasites  : pointers malaria treatment cancer chemotherapy. Trends Parasitol
                                              2005;21:292â€“298. [PubMed: 15922251]
                                          Opperdoes FR, Coombs GH. Metabolism Leishmania: proven predicted. Trends Parasitol
                                              2007;23:149â€“158. [PubMed: 17320480]
                                          Ouellette M, Drummelsmith J, El-Fadili  Kundig C, Richard D, Roy G. Pterin transport metabolism
                                              Leishmania related trypanosomatid parasites. Int J Parasitol 2002;32:385â€“398. [PubMed:
                                              11849635]
NIH-PA Author Manuscript




                                          Papadopoulou B, Dumas C. Parameters controlling rate gene targeting frequency protozoan
                                              parasite Leishmania. Nucleic Acids Res 1997;25:4278â€“4286. [PubMed: 9336458]
                                          Parle-McDermott  Pangilinan F, Mills JL, Signore CC, Molloy  Cotter  Conley M, Cox C, Kirke
                                              PN, Scott JM, Brody LC. polymorphism MTHFD1 gene increases motherâ€™s risk having
                                              unexplained second trimester pregnancy loss. Mol Hum Reprod 2005;11:477â€“480. [PubMed:
                                              16123074]
                                          Patel H, Pietro ED, MacKenzie  Mammalian fibroblasts lacking mitochondrial NAD+-dependent
                                              methylenetetrahydrofolate dehydrogenase-cyclohydrolase glycine auxotrophs. J Biol Chem
                                              2003;278:19436â€“19441. [PubMed: 12646567]
                                          Pawelek PD, MacKenzie  Methenyltetrahydrofolate cyclohydrolase rate limiting enzymatic
                                              conversion 10-formyltetrahydrofolate 5,10-methylenetetrahydrofolate bifunctional
                                              dehydrogenase-cyclohydrolase enzymes. Biochemistry 1998;37:1109â€“1115. [PubMed: 9454603]
                                          Peacock CS, Seeger K, Harris D, Murphy L, Ruiz JC, Quail MA, Peters N, Adlem E, Tivey  Aslett M,
                                              Kerhornou  Ivens  Fraser  Rajandream MA, Carver T, Norbertczak H, Chillingworth T, Hance
                                               Jagels K, Moule S, Ormond D, Rutter S, Squares R, Whitehead S, Rabbinowitsch E, Arrowsmith
                                              C, White B, Thurston S, Bringaud F, Baldauf SL, Faulconbridge  Jeffares D, Depledge DP, Oyola
                                               Hilley JD, Brito LO, Tosi LR, Barrell B, Cruz AK, Mottram JC, Smith DF, Berriman M.
                                              Comparative genomic analysis Leishmania species cause diverse human disease. Nat
                                              Genet 2007;39:839â€“847. [PubMed: 17572675]
NIH-PA Author Manuscript




                                          Prabhu V, Chatson KB, Lui H, Abrams GD, King J. Effects sulfanilamide methotrexate 13C
                                              fluxes glycine decarboxylase/serine hydroxymethyltransferase enzyme                                               arabidopsis. Plant Physiol 1998;116:137â€“144. [PubMed: 9449840]
                                          Rabinowitz JC. Preparation properties 5,10-methenyltetrahydrofolic acid 10-
                                              Formyltetrahydrofolic acid. Methods Enzymology 1963;6:814â€“815.
                                          Rabinowitz JC, Pricer Jr. Formyltetrahydrofolate synthetase.  Isolation crystallization                                               enzyme. J Biol Chem 1962;237:2898â€“2902. [PubMed: 14489619]
                                          RajBhandary UL. Initiator transfer RNAs. J Bacteriol 1994;176:547â€“552. [PubMed: 7507918]
                                          RajBhandary UL. surprises translation: initiation initiator tRNA. Proc Natl Acad Sci
                                              U S 2000;97:1325â€“1327. [PubMed: 10677458]
                                          Robinson KA, Beverley SM. Improvements transfection efficiency tests RNA interference
                                              (RNAi) approaches protozoan parasite Leishmania. Mol Biochem Parasitol 2003;128:217â€“
                                              228. [PubMed: 12742588]



                                                Mol Microbiol. Author manuscript; available PMC 2009 June 8.
                            Murta et al.                                                                                                     Page 18


                                          Schmidt  Wu H, MacKenzie  Chen VJ, Bewly JR, Ray JE, Toth JE, Cygler M. Structures                                               inhibitor complexes provide insight reaction mechanism human
                                              methylenetetrahydrofolate dehydrogenase/cyclohydrolase. Biochemistry 2000;39:6325â€“6335.
NIH-PA Author Manuscript




                                              [PubMed: 10828945]
                                          Schweitzer BI, Dicker AP, Bertino JR. Dihydrofolate reductase therapeutic target. FASEB J
                                              1990;4:2441â€“2452. [PubMed: 2185970]
                                          Scott DA, Coombs GH, Sanderson  Folate utilization Leishmania species identification
                                              intracellular derivatives folate-metabolizing enzymes. Mol Biochem Parasitol 1987;23:139â€“
                                              149. [PubMed: 3574356]
                                          Scott DA, Hickerson SM, Vickers TJ, Beverley SM. role mitochondrial glycine cleavage
                                              complex metabolism virulence protozoan parasite Leishmania major. J Biol Chem
                                              2008;283:155â€“165. [PubMed: 17981801]
                                          Sen N, Banerjee B, Gupta SS, Das BB, Ganguly  Majumder HK. Leishmania donovani:
                                              dyskinetoplastid cells survive proliferate presence pyruvate uridine                                               undergo apoptosis treatment camptothecin. Exp Parasitol 2007;115:215â€“219. [PubMed:
                                              17027973]
                                          Spencer AC, Spremulli LL. Interaction mitochondrial initiation factor 2 mitochondrial fMet-
                                              tRNA. Nucleic Acids Res 2004;32:5464â€“5470. [PubMed: 15477394]
                                          Stanger O. Physiology folic acid health disease. Curr Drug Metab 2002;3:211â€“223. [PubMed:
                                              12003352]
                                          Szewczyk E, Nayak T, Oakley CE, Edgerton H, Xiong Y, Taheri-Talesh N, Osmani SA, Oakley BR.
NIH-PA Author Manuscript




                                              Fusion PCR gene targeting Aspergillus nidulans. Nat Protoc 2006;1:3111â€“3120. [PubMed:
                                              17406574]
                                          Tan LU, Drury EJ, MacKenzie  Methylenetetrahydrofolate dehydrogenase-methenyltetrahydrofolate
                                              cyclohydrolase-formyltetrahydrofolate synthetase. multifunctional protein porcine liver. J
                                              Biol Chem 1977;252:1117â€“1122. [PubMed: 838698]
                                          Tan TH, Bochud-Allemann N, Horn EK, Schneider  Eukaryotic-type elongator tRNAMet                                               Trypanosoma brucei formylated import mitochondria. Proc Natl Acad Sci U S                                               2002;99:1152â€“1157. [PubMed: 11792845]
                                          Temple C Jr, Bennett LL Jr, Rose JD, Elliott RD, Montgomery JA, Mangum JH. Synthesis pseudo
                                              cofactor analogues potential inhibitors folate enzymes. J Med Chem 1982;25:161â€“166.
                                              [PubMed: 7057422]
                                          RL. Antimicrobial dihydrofolate reductase inhibitors--achievements future options: review. J
                                              Chemother 2004;16:3â€“12. [PubMed: 15077993]
                                          Tonkinson JL, Habeck LL, Toth JE, Mendelsohn LG, Bewley J, Shackelford KA, Gates SB, Ray J, Chen
                                              VJ. antiproliferative cell cycle effects 5,6,7, 8-tetrahydro-N5, N10-carbonylfolic acid,                                               inhibitor methylenetetrahydrofolate dehydrogenase, potentiated hypoxanthine. J Pharmacol
                                              Exp Ther 1998;287:315â€“321. [PubMed: 9765352]
                                          Varshney U, Lee CP, RajBhandary UL. elongator tRNA initiator tRNA. Proc Natl Acad Sci U
                                              S 1993;90:2305â€“2309. [PubMed: 8460138]
NIH-PA Author Manuscript




                                          Vergnes B, Sereno D, Tavares J, Cordeiro-da-Silva  Vanhille L, Madjidian-Sereno N, Depoix D,
                                              Monte-Alegre  Ouaissi  Targeted disruption cytosolic SIR2 deacetylase discloses essential
                                              role Leishmania survival proliferation. Gene 2005;363:85â€“96. [PubMed: 16236469]
                                          Vial L, Gomez P, Panvert M, Schmitt E, Blanquet S, Mechulam Y. Mitochondrial methionyl-tRNAfMet
                                              formyltransferase Saccharomyces cerevisiae: gene disruption tRNA substrate specificity.
                                              Biochemistry 2003;42:932â€“939. [PubMed: 12549912]
                                          Vickers TJ, Murta SMF, Mandell MA, Beverley SM. 10-formyl-tetrahydrofolate synthesis exclusively
                                              cytosolic trypanosomatid parasite. Leishmania major. 2008(submitted)
                                          Vickers TJ, Orsomando G, la Garza RD, Scott DA, Kang  Hanson AD, Beverley SM. Biochemical
                                              genetic analysis methylenetetrahydrofolate reductase Leishmania metabolism                                               virulence. J Biol Chem 2006;281:38150â€“38158. [PubMed: 17032644]
                                          Weber S. Light-driven enzymatic catalysis DNA repair: review recent biophysical studies                                               photolyase. Biochim Biophys Acta 2005;1707:1â€“23. [PubMed: 15721603]



                                                Mol Microbiol. Author manuscript; available PMC 2009 June 8.
                            Murta et al.                                                                                                 Page 19


                                          West MG, Horne DW, Appling DR. Metabolic role cytoplasmic isozymes 5,10-
                                             methylenetetrahydrofolate dehydrogenase Saccharomyces cerevisiae. Biochemistry
                                             1996;35:3122â€“3132. [PubMed: 8608153]
NIH-PA Author Manuscript




                                          Zhang Y, Desharnais J, Marsilje TH, Li C, Hedrick MP, Gooljarsingh LT, Tavassoli  Benkovic SJ,
                                             Olson AJ, Boger DL, Wilson IA. Rational design, synthesis, evaluation, crystal structure                                              potent inhibitor human GAR Tfase: 10-(trifluoroacetyl)-5,10-dideazaacyclic-5,6,7,8-
                                             tetrahydrofolic acid. Biochemistry 2003;42:6043â€“6056. [PubMed: 12755606]
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                                Mol Microbiol. Author manuscript; available PMC 2009 June 8.
                            Murta et al.                                                                                          Page 20
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                          FIG. 1. 10-formyl-THF metabolism Leishmania
                                          Following synthesis activity dihydrofolate reductase (DHFR, encoded                                           bifunctional DHFR-TS) pteridine reductase 1 (PTR1), tetrahydrofolate (THF) enter C1
                                          metabolic pathways direct formylation ATP-dependent reaction formate-
                                          tetrahydrofolate ligase (FTL, LmjF30.2600). Alternatively, THF converted 5,10-
                                          methylene-tetrahydrofolate (5,10-CH2-THF) activity serine
                                          hydroxymethyltransferase (SHMT). 10-CHO-THF generated steps 5,10-
                                          methylene-tetrahydrofolate (5,10-CH2-THF), oxidation 5,10-methenyl-
                                          tetrahydrofolate (5,10-CH=THF) NADP+-dependent methylenetetrahydrofolate
                                          dehydrogenase (DH, LmjF26.0320), hydrolysis 10-CHO-THF                                           methenyltetrahydrofolate cyclohydrolase (CH, LmjF26.0320). L. major DH CH
NIH-PA Author Manuscript




                                          activities contained single bifunctional protein DHCH1, like FTL localized
                                          exclusively cytosol (Vickers et al., 2008). 10-CHO-THF used novo
                                          purine synthetic pathway organisms, pathway absent Leishmania                                           parasitic protozoans (Carter et al., 2008). Current data suggest 10-CHO-THF utilized
                                          mitochondrion methionyl-tRNA formylation, unique function far
                                          uncovered genomic metabolic studies Leishmania.




                                               Mol Microbiol. Author manuscript; available PMC 2009 June 8.
                            Murta et al.                                                                                         Page 21
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                          FIG. 2. Attempts generate dhch1âˆ’ null mutants â€˜classicâ€™ double replacements
                                           Planned deletion DHCH1 ORF homologous gene replacement using targeting
                                          fragments PAC HYG resistance markers. round, parasites transfected
                                          construct separately; diagram round starting PAC shown.
                                          Heterozygous replacement lines obtained high efficiency. second round,                                           +/PAC heterozygote (formally, Î”dhch1::PAC/DHCH) transfected HYG targeting
                                          fragment, expectation yielding homozogous dhch1âˆ’ null mutants. Instead,                                           aneuploid parasites showing planned replacements retaining WT DHCH1
                                          recovered (formally, Î”dhch1::PAC/DHCH/Î”dhch1::SAT/Î”dhch1::PAC/DHCH1). B.
                                          PCR tests planned PAC replacements DHCH1. Homologous replacement visualized
                                          PCR amplification using primer directed sequences located PAC ORF,
                                          primer located DHCH1 chromosome outside targeting fragment (indicated                                           heavy line) 5â€² (white arrows) 3â€² (black arrow) (SMB2731/2558                                           SMB2771/2557, Table S1). sizes predicted PCR products shown. WT, wild-
                                          type DNA; NC, negative control  DNA template), #1â€“8, independent lines                                           PAC replacements DHCH1. C, PCR tests planned HYG replacements DHCH1. NIH-PA Author Manuscript




                                          experiment similar described panel B, primers directed                                           sequences located HYG targeting fragment (SMB2731/2562 SMB2771/2561, Table
                                          S1). #1â€“6, independent lines HYG replacements DHCH1. D. PCR tests showing
                                          retention DHCH1 second round transfectants. Amplifications performed using
                                          primers directed sequences L. major DHCH1 ORF (SMB3125/3126, Table
                                          S1). Lines # 1 â€“ 4 represent double replacement PAC/HYG lines # 5 â€“ 8 HYG/
                                          PAC.




                                               Mol Microbiol. Author manuscript; available PMC 2009 June 8.
                            Murta et al.                                                                                       Page 22
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                          FIG. 3. Deletion chromosomal DHCH1 presence ectopic DHCH1
NIH-PA Author Manuscript




                                           Scheme deletion chromosomal DHCH1 presence ectopically expressed
                                          DHCH1.  pXNG4-DHCH1 episomal expression construct transfected                                           DHCH1/Î”dhch1::PAC heterozygote described Fig. 2A; 10/10 transfectants analyzed                                           confirmed predicted genotype depicted. DHCH1/Î”dhch1::PAC [pXNG4-
                                          DHCH1] lines transfected HYG DHCH targeting fragment selected                                           resistance antibiotics; 12 clonal lines tested, showed planned
                                          replacement chromosomal DHCH1 locus (formally, Î”dhch1::HYG DHCH1/
                                          Î”dhch1::PAC [pXNG4-DHCH1]).
                                          B â€“ PCR tests showing loss chromosomal DHCH1. distinguish ectopic DHCH1
                                          chromosomal locus, DNA candidate lines subjected PCR tests using                                           using primer directed sequences located DHCH1 ORFt, primer located
                                          DHCH1 chromosome outside targeting fragment 5â€² (SMB2731/3126,,
                                          Table S1). WT, wild-type DNA control; NC, negative control lacking DNA template. 


                                               Mol Microbiol. Author manuscript; available PMC 2009 June 8.
                            Murta et al.                                                                                      Page 23


                                          arrow marks size predicted fragment WT DNA, absent                                           chromosomal dhch1âˆ’ knockouts.
NIH-PA Author Manuscript
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                               Mol Microbiol. Author manuscript; available PMC 2009 June 8.
                            Murta et al.                                                                                          Page 24
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                          FIG. 4. Deletion chromosomal DHCH1 presence ectopic FTL overexpression
                                           Scheme deletion chromosomal DHCH1 presence ectopically expressed
                                          FTL. pXNG4-FTLepisomal expression construct transfected DHCH1/PAC
                                          (DHCH1/Î”dhch1::PAC) heterozygote described Fig. 2A; 10/10 transfectants analyzed                                           predicted genotype depicted. DHCH1/PAC/+FTL lines (DHCH1/Î”dhch1::PAC
                                          [pXNG4-FTL]) transfected HYG DHCH1 targeting fragment described
                                          legend Fig. 3A; 12 clonal lines tested, showed planned replacement                                           chromosomal DHCH1 locus dhch1âˆ’/+FTL (Î”dhch1::HYG DHCH1/
                                          Î”dhch1::PAC [pXNG4-FTL]).
                                          B â€“ PCR tests showing loss chromosomal DHCH1. performed described                                           legend Fig. 3B. NC, negative control lacking DNA; WT, WT DNA; pXNG-DHCH1,
                                          WT transfected pXNG-DHCH1. Pac4, Pac5, Hyg7 different lines showing
NIH-PA Author Manuscript




                                          absence predicted chromosomal DHCH1 PCR product (shown arrow). C. Western
                                          blot showing loss DHCH1 expression dhch1âˆ’/+FTL transfectants. lines         